title: The burden of Chagas disease: estimates and challenges.
abstract: Chagas disease, caused by infection with the protozoa Trypanosoma cruzi is transmitted most often by Triatominae insect vectors, but also through blood transfusion, organ transplant, and congenital transmission. Between 5 and 18 million people are currently infected and the infection is estimated to cause more than 10,000 deaths annually. The disease has 3 phases: acute, indeterminate, and chronic. The acute phase immediately follows infection. It is typically asymptomatic but produces fever and malaise in up to 5% of people. The indeterminate phase is asymptomatic. More than one-half of those infected will remain in this phase for life and never experience long-term sequelae. After a decade or more, 20% to 30% of people will experience chronic cardiovascular Chagas disease with sequelae including heart failure, arrhythmias, and thromboembolism. Another 15% to 20% will experience chronic digestive sequela including megaesophagus and megacolon. A complete accounting of the burden of Chagas disease requires estimating the prevalence of the infection, the prevalence of each of its sequelae among those with the infection, and the number of deaths attributable to the infection. Attempts to estimate Chagas disease prevalence are complicated by several challenges imposed by the disease's extreme spatial heterogeneity, quickly evolving temporal trends, the decades-long lag between infection and symptomatic disease, biased prevalence data, incomplete recognition of Chagas-attributable deaths, limited data on sequela, and a near total absence of data outside of endemic countries. Even though researchers have found methodological approaches to dealing with these challenges, there is a need for better data.
authors.affiliation: Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA. Electronic address: stanaway@uw.edu.
authors.forename: Jeffrey D
authors.initials: JD
authors.lastname: Stanaway
authors.affiliation: Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA; Division of Cardiology, University of Washington, Seattle, WA, USA.
authors.forename: Gregory
authors.initials: G
authors.lastname: Roth
mesh_terms: D000208:Acute Disease; D000818:Animals; D002598:Chagas Cardiomyopathy / Q000453:epidemiology*; D014355:Chagas Disease / Q000150:complications / Q000453:epidemiology* / Q000635:transmission; D002908:Chronic Disease; D004931:Esophageal Achalasia / Q000453:epidemiology* / Q000209:etiology; D006801:Humans; D007303:Insect Vectors; D007843:Latin America / Q000453:epidemiology; D008531:Megacolon / Q000453:epidemiology* / Q000209:etiology; D015995:Prevalence; D014225:Triatominae; D014349:Trypanosoma cruzi